RPS4XP13

Across TCGA pan-cancer cohorts, RPS4XP13 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated RPS4XP13 data layer.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher RPS4XP13 RNA is associated with better overall survival. In most high-consensus cancer types, elevated RPS4XP13 expression acts as an unfavorable survival marker, although some lineages such as CESC and THCA show a favorable association.

CESC, THCA, and READ are the cancer types where RPS4XP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	All	0.713	0.450	<.001	76	view →
THCA	OS	Tertile	II,III,IV	1.000	0.646	.007	41	view →
READ	DFS	Tertile	II,III,IV	0.709	0.388	.002	41	view →
OV	OS	Median	II,III,IV	0.281	0.366	.007	28	view →
LUAD	OS	Median	III,IV	0.545	0.735	.023	21	view →
KICH	OS	Quartile	III,IV	0.206	0.771	.002	20	view →
ACC	DFS	Tertile	All	0.176	0.605	.001	20	view →
SKCM	OS	Tertile	III,IV	0.878	0.586	.002	16	view →
LUSC	OS	Quartile	II,III,IV	0.485	0.196	.011	12	view →
UCS	OS	Median	All	0.229	0.482	.011	10	view →
STAD	DFS	Tertile	IV	0.496	0.111	.045	6	view →
CHOL	OS	Quartile	II,III,IV	1.000	0.420	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

RPS4XP13–CESC (OS)

Open the CESC breakdown →